Epperla, N., Xu, Y., Bock, A., Baron, K., Fitzgerald, L., Shah, H., Ermann, D., Sehgal, L., Alinari, L., Hu, B. (2025). Trials in progress - A phase II study of pemigatinib in patients with relapsed or refractory B-cell non-Hodgkin lymphomas (PERFORM). Blood. https://doi.org/10.1182/blood-2025-8235